BTIG Sticks to Its Buy Rating for Globus Medical (GMED)
In a report released yesterday, Ryan Zimmerman from BTIG reiterated a Buy rating on Globus Medical (GMED – Research Report), with a price ...
Globus Medical reports Q4 EPS 84c, consensus 75c
Reports Q4 revenue $657.29M, consensus $646.19M. “I’m proud of our team at Globus Medical (GMED), delivering incredible results for 2024. We ...
Orthopedics This Week2d
Globus Medical Pays 38% Premium for Nevro
Globus Medical will acquire Nevro in an all-cash transaction. Both company boards of directors have unanimously approved the ...
Globus Medical's SWOT analysis: stock outlook amid acquisition and FDA warning
Globus Medical Inc. (NYSE:GMED), a leading medical device company specializing in musculoskeletal disorders, has been making waves in the healthcare sector with its recent acquisition of Nevro Corp ...
Nevro Corp's SWOT analysis: acquisition shakes up struggling SCS stock
Nevro Corp (NYSE:NVRO), a medical device company specializing in spinal cord stimulation (SCS) technology for chronic pain treatment, has recently undergone significant changes in its market position ...
Globus Medical: Some Caution After Its Deal For Nevro
Globus Medical started 2025 on a solid note, but a deal for loss-making Nevro creates some discomfort among investors. Read ...